← Back to Patent Explorer
EP0076647A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Culture media for cells originating from the immune system

Assignee: Hana Biologics Inc
•
Filing: 1982-09-30
•
Granted: —
•
Expires: 2002-09-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A culture medium, useful for the serum-free culturing of a variety of cells originating from the immune system and for culturing cells with a serum supplement, is disclosed. The cells to be cultured include, in addition to hybridomas, other cell types such as a variety of malignant cells of the immune system and normal lymphocytes.

Inventors

  • 👤 Kathelyn Sue Steimer

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-03 18:45
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/0634; C12N2500/00; C12N2500/05; C12N2500/10; C12N2500/20; C12N2500/24; C12N2500/25; C12N2500/30; C12N2500/32; C12N2500/36; C12N2500/38; C12N2500/40; C12N2500/90

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 548 words
A medium for culturing cells under serum-free or low serum conditions characterised in that the medium comprises: A. Growth factors selected from the group consisting of: 1. Approximately 0-100 µg/ml insulin 2. Approximately 1-100 µg/ml transferrin 3. Approximately 0-200 µM ethanolamine; B. Approximately 100-1000 µg per ml bovine serum albumin (BSA) complexed in a molar ratio ranging from 1:0.5 to 1:5 with at least one fatty acid selected from the group consisting of: 1. arachadonic acid 2. oleic acid 3. linoleic acid 4. palmitic acid 5. stearic acid 6. linolenic acid 7. palmitoleic acid; C. Amino acids selected from the group consisting of: 1. Approximately 0-100 mg/l L-alanine 2. Approximately 100-1000 mg/1 L-arginine 3. Approximately 0-100 mg/1 L-asparagine 4. Approximately 0-100 mg/l L-aspartic acid 5. Approximately 0-100 mg/1 L-glycine 6. Approximately 7.5-150 mg/1 L-histidine 7. Approximately 10-500 mg/l L-isoleucine 8. Approximately 25-500 mg/l L-leucine 9. Approximately 20-400 mg/l L-lysine HC1 10. Approximately 7.5-150 mg/l L-methionine 11. Approximately 0-150 mg/l L-serine 12. Approximately 10-200 mg/l L-threonine 13. Approximately 7.5-150 mg/l L-phenylalanine 14. Approximately 2.5-25 mg/l L-tryptophan 15. Approximately 10-100 mg/l L-valine 16. Approximately 0-100 mg/l L-glutamate 17. Approximately 0-200 mg/l L-proline 18. Approximately 0-100 mg/l hydroxy-L-proline 19. Approximately 10-100 mg/l tyrosine 20. Approximately 25-500 mg/l cystine 21. Approximately 100-3000 mg/l glutamine 22. Approximately 0-5.5 mg/l L-α-amino-n-butyric acid 23. Approximately 0-3.9 mg/l D-glucosamine HCl 24. Approximately 0-4.2 mg/l L-taurine 25. Approximately 0-9.4 mg/l L-ornithine HC1; D.Vitamins selected from the group consisting of: 1. Approximately 0-5 mg/l p-amino benzoic acid 2. Approximately 0-3 mg/l biotin 3. Approximately 0.1-3 mg/l d- C a-pantothenate 4. Approximately 1.0-10.0 mg/l choline chloride 5. Approximately 0.5-5 mg/l nicotinamide 6. Approximately 0.5-3 mg/l pyridoxine-HCl 7. Approximately 0.1-1.0 mg/1 riboflavin 8. Approximately 0.5-3.0 mg/l thiamine HC1 9. Approximately 0-10.0 mg/l vitamin B 12 10. Approximately 10.0-50.0 mg/l inositol 11. Approximately 0-0.025 mg/1 D-tacopherol acid succinate 12. Approximately 0-0.25 mg/1 calciferol 13. Approximately 0-0.025 mg/l menadione 14. Approximately 0-0.0625 mg/l niacin 15. Approximately 0-0.25 mg/l vitamin A 16. Approximately 0.5-3.0 mg/l folic acid; E. A balanced salt solution; F. Trace compounds selected from the group consisting of: 1. Approximately 0-0.01 mg/l CuS0 4 .5H 2 0 2. Approximately 0-1x10 -8 M FeS0 4 .7H 2 0 3. Approximately 0-0.1 mg/l ZnS0 4 .7H 2 0 4. Approximately 0-1x10 -7 M L iCl 5. Approximately 0-2.5x10 -6 M Na 2 SeO 4 ; G. Coenzymes selected from the group consisting of: 1. Approximately 0-0.25 mg/l coenzyme A 2. Approximately 0-0.7 mg/l diphosphopyridine nucleotide 3. Approximately 0-1.0 mg/l flavin adenine dinucleotide 4. Approximately 0-1.0 mg/l triphosphopyridine nucleotide 5. Approximately 0-1.0 mg/l cocarboxylase 6. Approximately 0-1.0 mg/l uridine triphosphate, sodium; H. Nucleic acid derivatives selected from the group consisting of: 1. Approximately 0-10 mg/l deoxyadenosine 2. Approximately 0-10 mg/l deoxyguanosine 3. Approximately 0-10 mg/l deoxycytidine HC1 4. Approximately 0-0.1 mg/1 5-methyl cytosine 5. Approximately 0-73 mg/l thymidine; and I. Additional components selected from the group consisting of: 1. Approximately 0-20 mg/l lipoic acid 2. Approximately 0-1000 mg/l sodium pyruvate 3. Approximately 0-40 mg/l hypoxanthine 4. Approximately 2000 mg/l NaHCO 3 5. Approximately 1000-4500 mg/l glucose 6. Approximately 0-20 mg/l phenol red 7. Approximately 0-10 mg/l gluthathione 8. Approximately 0.50 mg/l ascorbic acid 9. Approximately 0-1.8 mg/l D-glucuronolactone 10. Approximately 0-1.8 mg/l sodium glucuronate H 2 0 11. Approximately 0-12.5 mg/l Tween 80.
Claim 2
Independent Claim 548 words
A medium for culturing cells under serum-free or low serum conditions characterised in that the medium comprises: A. Growth factors selected from the group consisting of: 1. Approximately 0-100 µg/ml insulin 2. Approximately 1-100 µg/ml transferrin 3. Approximately 0-200 µM ethanolamine; B. Approximately 100-1000 µg per ml bovine serum albumin (BSA) complexed in a molar ratio ranging from 1:0.5 to 1:5 with at least one fatty acid selected from the group consisting of: 1. arachadonic acid 2. oleic acid 3. linoleic acid 4. palmitic acid 5. stearic acid 6. linolenic acid 7. palmitoleic acid; C. Amino acids selected from the group consisting of: 1. Approximately 0-100 mg/l L-alanine 2. Approximately 100-1000 mg/1 L-arginine 3. Approximately 0-100 mg/1 L-asparagine 4. Approximately 0-100 mg/l L-aspartic acid 5. Approximately 0-100 mg/1 L-glycine 6. Approximately 7.5-150 mg/1 L-histidine 7. Approximately 10-500 mg/l L-isoleucine 8. Approximately 25-500 mg/l L-leucine 9. Approximately 20-400 mg/l L-lysine HC1 10. Approximately 7.5-150 mg/l L-methionine 11. Approximately 0-150 mg/l L-serine 12. Approximately 10-200 mg/l L-threonine 13. Approximately 7.5-150 mg/l L-phenylalanine 14. Approximately 2.5-25 mg/l L-tryptophan 15. Approximately 10-100 mg/l L-valine 16. Approximately 0-100 mg/l L-glutamate 17. Approximately 0-200 mg/l L-proline 18. Approximately 0-100 mg/l hydroxy-L-proline 19. Approximately 10-100 mg/l tyrosine 20. Approximately 25-500 mg/l cystine 21. Approximately 100-3000 mg/l glutamine 22. Approximately 0-5.5 mg/l L-α-amino-n-butyric acid 23. Approximately 0-3.9 mg/l D-glucosamine HCl 24. Approximately 0-4.2 mg/l L-taurine 25. Approximately 0-9.4 mg/l L-ornithine HC1; D.Vitamins selected from the group consisting of: 1. Approximately 0-5 mg/l p-amino benzoic acid 2. Approximately 0-3 mg/l biotin 3. Approximately 0.1-3 mg/l d- C a-pantothenate 4. Approximately 1.0-10.0 mg/l choline chloride 5. Approximately 0.5-5 mg/l nicotinamide 6. Approximately 0.5-3 mg/l pyridoxine-HCl 7. Approximately 0.1-1.0 mg/1 riboflavin 8. Approximately 0.5-3.0 mg/l thiamine HC1 9. Approximately 0-10.0 mg/l vitamin B 12 10. Approximately 10.0-50.0 mg/l inositol 11. Approximately 0-0.025 mg/1 D-tacopherol acid succinate 12. Approximately 0-0.25 mg/1 calciferol 13. Approximately 0-0.025 mg/l menadione 14. Approximately 0-0.0625 mg/l niacin 15. Approximately 0-0.25 mg/l vitamin A 16. Approximately 0.5-3.0 mg/l folic acid; E. A balanced salt solution; F. Trace compounds selected from the group consisting of: 1. Approximately 0-0.01 mg/l CuS0 4 .5H 2 0 2. Approximately 0-1x10 -8 M FeS0 4 .7H 2 0 3. Approximately 0-0.1 mg/l ZnS0 4 .7H 2 0 4. Approximately 0-1x10 -7 M L iCl 5. Approximately 0-2.5x10 -6 M Na 2 SeO 4 ; G. Coenzymes selected from the group consisting of: 1. Approximately 0-0.25 mg/l coenzyme A 2. Approximately 0-0.7 mg/l diphosphopyridine nucleotide 3. Approximately 0-1.0 mg/l flavin adenine dinucleotide 4. Approximately 0-1.0 mg/l triphosphopyridine nucleotide 5. Approximately 0-1.0 mg/l cocarboxylase 6. Approximately 0-1.0 mg/l uridine triphosphate, sodium; H. Nucleic acid derivatives selected from the group consisting of: 1. Approximately 0-10 mg/l deoxyadenosine 2. Approximately 0-10 mg/l deoxyguanosine 3. Approximately 0-10 mg/l deoxycytidine HC1 4. Approximately 0-0.1 mg/1 5-methyl cytosine 5. Approximately 0-73 mg/l thymidine; and I. Additional components selected from the group consisting of: 1. Approximately 0-20 mg/l lipoic acid 2. Approximately 0-1000 mg/l sodium pyruvate 3. Approximately 0-40 mg/l hypoxanthine 4. Approximately 2000 mg/l NaHCO 3 5. Approximately 1000-4500 mg/l glucose 6. Approximately 0-20 mg/l phenol red 7. Approximately 0-10 mg/l gluthathione 8. Approximately 0.50 mg/l ascorbic acid 9. Approximately 0-1.8 mg/l D-glucuronolactone 10. Approximately 0-1.8 mg/l sodium glucuronate H 2 0 11. Approximately 0-12.5 mg/l Tween 80.
Claim 3
Independent Claim 536 words
A medium culturing cells under serum-free or low serum conditions characterised in that the medium comprises: A. Growth factors selected from the group consisting of: 1. Approximately 5 µg/ml insulin 2. Approximately 50 µg/ml transferrin 3. Approximately 20 µM ethanolamine; B. Approximately 100-1000 µg/ml of Bovine serum albumin (BSA) complexed in a 1:1 molar ratio with each of the following fatty acids: 1. arachadonic acid 2. oleic acid 3. linoleic acid 4. palmitic acid 5. stearic acid 6. linolenic acid 7. palmitoleic acid; C. Amino acids selected from the group consisting of: 1. Approximately 10 mg/l L-alanine 2. Approximately 200 mg/l L-arginine 3. Approximately 50 mg/l L-asparagine 4. Approximately 20 mg/l L-aspartic acid 5. Approximately 10 mg/1 L-glycine 6. Approximately 15 mg/l L-histidine 7. Approximately 50 mg/l L-isoleucine 8. Approximately 50 mg/l L-leucine 9. Approximately 40 mg/l L-lysine HC1 10. Approximately 15 mg/l L-methionine 11. Approximately 30 mg/l L-serine 12. Approximately 20 mg/l L-threonine 13. Approximately 15 mg/l L-phenylalanine 14. Approximately 5 mg/l L-tryptophan 15. Approximately 20 mg/l L-valine 16. Approximately 20 mg/l L-glutamate 17. Approximately 20 mg/l L-proline 18. Approximately 20 mg/l hydroxy-L-proline 19. Approximately 20 mg/l tyrosine 20. Approximately 50 mg/l cystine 21. Approximately 300 mg/l glutamine 22. Approximately 0.55 mg/l L-α-amino-n-butyric acid 23. Approximately 0.39 mg/l D-glucosamine HCl 24. Approximately 0.42 mg/l L-taurine 25. Approximately 0.94 mg/l L-ornithine HC1; D. Vitamins selected from the group consisting of: 1. Approximately 1 mg/l p-aminobenzoic acid 2. Approximately 0.2 mg/l biotin 3. Approximately 0.25 mg/l d-Ca-pantothenate 4. Approximately 3 mg/l choline chloride 5. Approximately 1 mg/l nicotinamide 6. Approximately 1 mg/l pxridoxine-HCl 7. Approximately 0.2 mg/l riboflavin 8. Approximately 1 mg/l thiamine HC1 9 . Approximately 1.0 mg/l vitamin B 12 10. Approximately 35 mg/l inositol 11. Approximately 0.0025 mg/l D-tacopherol acid succinate 12. Approximately 0.025 mg/l calciferol 13. Approximately 0.0025 mg/l menadione 14. Approximately 0.00625 mg/l niacin 15. Approximately 0.025 mg/l vitamin A 16. Approximately 1 mg/l folic acid; E. A balanced salt solution; F. Trace compounds selected from the group consisting of: 1. Approximately 0.00125 mg/l CuS0 4 .5H 2 0 2. Approximately 10 -10 M FeSO 4 ·7H 2 O 3. Approximately 0.028 mg/l ZnS0 4 .7H 2 0 4. Approximately 10 -9 M LiCl 5. Approximately 2.5x10 -8 M Na 2 SeO 4 ; G. Coenzymes selected from the group consisting of: 1. Approximately 0.025 mg/l coenzyme A 2. Approximately 0.07 mg/l diphosphorpyridine nucleotide 3. Approximately 0.1 mg/l flavin adenine dinucleotide 4. Approximately 0.1 mg/l triphosphopyridine nucleotide 5. Approximately 0.1 mg/l cocarboxylase 6. Approximately 0.1 mg/l uridine triphosphate sodium; H . Nucleic acid derivatives selected from the group consisting of: 1. Approximately 1 mg/l deoxyadenosine 2. Approximately 1 mg/l deoxyguanosine 3. Approximately 1 mg/l deoxycytidine HC1 4. Approximately 0.02 mg/1 5-methyl cytosine 5. Approximately 1 mg/l thymidine; and I. Additional components selected from the group consisting of: 1. Approximately 0.2 mg/l lipoic acid 2. Approximately 110 mg/l sodium pyruvate 3. Approximately 4 mg/l hypoxanthine 4. Approximately 200 mg/l NaHCO 3 5. Approximately 2000 mg/l glucose 6. Approximately 5 mg/l phenol red 7. Approximately 1 mg/l gluthathione 8. Approximately 5 mg/l ascorbic acid 9. Approximately 0.18 mg/l D-glucuronolactone 10. Approximately 0.18 mg/l sodium glucuronate H 2 0 11. Approximately 1.25 mg/l Tween 80.
Claim 4
Independent Claim 536 words
A medium culturing cells under serum-free or low serum conditions characterised in that the medium comprises: A. Growth factors selected from the group consisting of: 1. Approximately 5 µg/ml insulin 2. Approximately 50 µg/ml transferrin 3. Approximately 20 µM ethanolamine; B. Approximately 100-1000 µg/ml of Bovine serum albumin (BSA) complexed in a 1:1 molar ratio with each of the following fatty acids: 1. arachadonic acid 2. oleic acid 3. linoleic acid 4. palmitic acid 5. stearic acid 6. linolenic acid 7. palmitoleic acid; C. Amino acids selected from the group consisting of: 1. Approximately 10 mg/l L-alanine 2. Approximately 200 mg/l L-arginine 3. Approximately 50 mg/l L-asparagine 4. Approximately 20 mg/l L-aspartic acid 5. Approximately 10 mg/1 L-glycine 6. Approximately 15 mg/l L-histidine 7. Approximately 50 mg/l L-isoleucine 8. Approximately 50 mg/l L-leucine 9. Approximately 40 mg/l L-lysine HC1 10. Approximately 15 mg/l L-methionine 11. Approximately 30 mg/l L-serine 12. Approximately 20 mg/l L-threonine 13. Approximately 15 mg/l L-phenylalanine 14. Approximately 5 mg/l L-tryptophan 15. Approximately 20 mg/l L-valine 16. Approximately 20 mg/l L-glutamate 17. Approximately 20 mg/l L-proline 18. Approximately 20 mg/l hydroxy-L-proline 19. Approximately 20 mg/l tyrosine 20. Approximately 50 mg/l cystine 21. Approximately 300 mg/l glutamine 22. Approximately 0.55 mg/l L-α-amino-n-butyric acid 23. Approximately 0.39 mg/l D-glucosamine HCl 24. Approximately 0.42 mg/l L-taurine 25. Approximately 0.94 mg/l L-ornithine HC1; D. Vitamins selected from the group consisting of: 1. Approximately 1 mg/l p-aminobenzoic acid 2. Approximately 0.2 mg/l biotin 3. Approximately 0.25 mg/l d-Ca-pantothenate 4. Approximately 3 mg/l choline chloride 5. Approximately 1 mg/l nicotinamide 6. Approximately 1 mg/l pxridoxine-HCl 7. Approximately 0.2 mg/l riboflavin 8. Approximately 1 mg/l thiamine HC1 9 . Approximately 1.0 mg/l vitamin B 12 10. Approximately 35 mg/l inositol 11. Approximately 0.0025 mg/l D-tacopherol acid succinate 12. Approximately 0.025 mg/l calciferol 13. Approximately 0.0025 mg/l menadione 14. Approximately 0.00625 mg/l niacin 15. Approximately 0.025 mg/l vitamin A 16. Approximately 1 mg/l folic acid; E. A balanced salt solution; F. Trace compounds selected from the group consisting of: 1. Approximately 0.00125 mg/l CuS0 4 .5H 2 0 2. Approximately 10 -10 M FeSO 4 ·7H 2 O 3. Approximately 0.028 mg/l ZnS0 4 .7H 2 0 4. Approximately 10 -9 M LiCl 5. Approximately 2.5x10 -8 M Na 2 SeO 4 ; G. Coenzymes selected from the group consisting of: 1. Approximately 0.025 mg/l coenzyme A 2. Approximately 0.07 mg/l diphosphorpyridine nucleotide 3. Approximately 0.1 mg/l flavin adenine dinucleotide 4. Approximately 0.1 mg/l triphosphopyridine nucleotide 5. Approximately 0.1 mg/l cocarboxylase 6. Approximately 0.1 mg/l uridine triphosphate sodium; H . Nucleic acid derivatives selected from the group consisting of: 1. Approximately 1 mg/l deoxyadenosine 2. Approximately 1 mg/l deoxyguanosine 3. Approximately 1 mg/l deoxycytidine HC1 4. Approximately 0.02 mg/1 5-methyl cytosine 5. Approximately 1 mg/l thymidine; and I. Additional components selected from the group consisting of: 1. Approximately 0.2 mg/l lipoic acid 2. Approximately 110 mg/l sodium pyruvate 3. Approximately 4 mg/l hypoxanthine 4. Approximately 200 mg/l NaHCO 3 5. Approximately 2000 mg/l glucose 6. Approximately 5 mg/l phenol red 7. Approximately 1 mg/l gluthathione 8. Approximately 5 mg/l ascorbic acid 9. Approximately 0.18 mg/l D-glucuronolactone 10. Approximately 0.18 mg/l sodium glucuronate H 2 0 11. Approximately 1.25 mg/l Tween 80.
Claim 5
Dependent Claim 30 words
A culture medium according to claim 1 characterised in that the bovine serum albumin is complexed in an approximately 1:1 molar ratio with one or more of the fatty acids.
Claim 6
Dependent Claim 28 words
A culture medium according to claim 1 or claim 3 characterised in that at least some palmitic acid and stearic acid complexed with bovine serum albumin is present.
Claim 7
Dependent Claim 58 words
A culture medium according to any preceding claim characterised in that the balanced salt solution comprises Earle's salts (a. approximately 100 mg/l Ca(NO 3 ) 2 ·4H 2 O b. approximately 400 mg/l KC1 c. approximately 100 mg/l MgS0 4 .7H 2 0 d. approximately 6000 mg/l NaCl e . approximately 800 mg/l Na 2 HPO 4 ).
Claim 8
Dependent Claim 23 words
A culture medium according to any of claims 1 to 4 characterised in that the balanced salt solution comprises Hank's balanced salt solution.
Claim 9
Dependent Claim 50 words
A culture medium according to any preceding claim characterised in that the medium further comprises N'--2-hydroxyethyl piperazine-N-ethane-sulphonic acid as a buffer system either substituted for the carbonate--bicarbonate buffer described in claims 1 or 2 or as a secondary buffer in combination with the carbonate--bicarbonate described in claims 1 and 2.
Claim 10
Dependent Claim 20 words
The use of a culture medium according to any preceding claim for culturing SP2/0-Ag-14 myeloma cells or SP2/0-Ag-14 hybridoma cells.
Claim 11
Dependent Claim 58 words
The use of a culture medium according to any of claims 1 to 7 for culturing.P3-NS-1-Ag-4-1 hybridoma cells, FO mouse myeloma and hybridoma cells, human lymphoblastoid cells, MPC-11 myeloma and hybridoma cells, cell lines originating from the immune system, or normal cells of the immune system cultured either as individually purified cell populations or as mixture of cells.
Claim 12
Dependent Claim 16 words
The use of a culture medium according to any of claims 1 to 7 with serum:
Claim 13
Dependent Claim 43 words
The use of the basal medium of claim 1 or claim 2 (all of the components except insulin, transferrin, ethanolamine, and fatty acid linked BSA) for culturing any cells originating from the immune system with any serum, from any species at any concentration.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag